Prospective dialogue between developers and regulators makes for better evidence generation

27 May 2020 - EMA, in collaboration with other parties, has recently published two scientific articles outlining the importance of ...

Read more →

Medicines New Zealand consulting on a new generation medicines policy

26 May 2020 - The New Zealand Institute of Economic Research have produced a discussion paper for Medicines New Zealand ...

Read more →

Inside the science: companies racing to develop a COVID-19 vaccine

25 May 2020 - Even as some states move to ease the lockdowns that have cost tens of millions of ...

Read more →

Trump admin taps startup to build nation's first stockpile of key drug ingredients

19 May 2020 - The $354 million project is designed to shore up the drug supply chain and reduce the country's ...

Read more →

Top pharma official rejects idea of free COVID-19 vaccine for all

18 May 2020 - A leading representative of the pharmaceutical industry has downplayed the idea of a vaccine against the ...

Read more →

A drug company wagers the U.S. won’t dare charge it with crimes

15 May 2020 - Teva, the world’s largest maker of generic drugs, recently pulled out of settlement talks with the Justice ...

Read more →

The pandemic is a chance to revamp India’s pharmaceutical industry

9 May 2020 - Companies could switch from primarily making generics to producing higher-margin licensed drugs. ...

Read more →

Medicines Australia joins forces with 15 health care organisations to highlight continuity of care

6 May 2020 - Right now, more than ever, it is essential that Australians maintain their health. Therefore, Medicines Australia ...

Read more →

Medicines Australia reinforces need for continued collaborative commitment to Australia’s medicine supplies

26 April 2020 - Medicines Australia has today reiterated the critical need for continued and transparent collaboration to support the ...

Read more →

Drug makers prepare to make coronavirus treatments

23 April 2020 - Preparations would help make doses rapidly if testing pans out, but companies risk large outlays if the ...

Read more →

Coronavirus puts big pharma’s IP regime to the test

21 April 2020 - “Chaotic” is how Jorge Contreras, a law professor at the University of Utah, describes a struggle ...

Read more →

If pharma helps quench the COVID-19 pandemic, what will it want in return?

21 April 2020 - Make no mistake: the only long-term solution to the COVID-19 pandemic is a safe and effective ...

Read more →

Big pharma has the chance to come to the world’s rescue

20 April 2020 - The pandemic may finally do for the pharmaceutical industry what relentless TV advertising cannot: show off its ...

Read more →

NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options

17 April 2020 - The National Institutes of Health (NIH) and the Foundation for the NIH are bringing together more than ...

Read more →

Aid groups ask UK gov to stop pharma 'profiteering' from COVID-19

16 April 2020 - As of this morning – Thursday April 16 – the current recorded case count for COVID-19 ...

Read more →